Abstract
Differentiated thyroid cancer (TC) is the most frequent type, with a good prognosis. However, around 10% of the cases progress with metastases, lose the ability to capture radioiodine and no longer respond to conventional radioiodine therapy. Anaplastic (ATC) carcinomas are the rarest (1-2%) and the most aggressive TC, are highly undifferentiated, do not capture radioiodine, and do not re…